Assertio HoldingsNASDAQ: ASRT

LAKE FOREST, Ill., June 06, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that effective May 31, 2024, the Compensation Committee of the Company's Board of Directors granted the Company's new Chief Executive Officer, Brendan P. O'Grady, 500,000 restricted stock units (“RSUs”) and 1,800,000 stock options (“options”).

Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a pharmaceutical company providing unique products to patients, stated that Ajay Patel, Chief Financial Officer, will be hosting investor meetings during the Benchmark & Company Healthcare House Call Virtual Conference on May 21-22, 2024.

A letter has been issued expressing concerns and recommending further investigation. It urges Assertio stockholders to vote against all directors at the upcoming annual meeting to either pressure the current board to accept new stockholder-recommended directors or force resignations of a significant portion of the board. The letter was released by The Buxton Helmsley Group, Inc., a New York City-based investment fund manager with a significant interest in Assertio Holdings, Inc. It was written by Rumbi B. Petrozzello, a Certified Public Accountant and Certified Fraud Examiner who previously served as President of the New York State Society of CPAs.

Assertio Holdings, Inc. (NASDAQ:ASRT) will be holding its Q1 2024 Earnings Conference Call on May 6, 2024 at 4:30 PM ET. Present on the call will be Matthew Kreps from Darrow Associates, Heather Mason as the Interim CEO, Ajay Patel as the CFO, and Paul Schwichtenberg as the Chief Commercial Officer. The conference call will be moderated by Jim Sidoti from Sidoti & Company and Thomas Flaten from Lake Street Capital Markets. The call will begin with opening remarks from Matt Kreps, Investor Relations for the company. Thank you.

LAKE FOREST, Ill., April 01, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that Ajay Patel, Chief Financial Officer, will present at the LD Micro Invitational XIV Conference to be held April 9, 2024 in New York City.

Assertio (ASRT) appears weighed down by the recent leadership transition. The company is also facing challenges with sales of its product franchisee of late.

Assertio Holdings has dropped substantially and is down more than 70% in the past year. Assertio Holdings appears to have been oversold based on quantitative factors. It trades at a very low enterprise value to revenue ratio compared to its peers. Diversification is important in managing the risk associated with distressed equities like Assertio. I'm issuing a Buy rating but suggest diversifying.

Assertio (ASRT) appoints Heather Mason as its interim CEO as its current CEO, Dan Peisert, steps down from his role. Shares of the company fall on the same.

Today's backdrop of a predicted fall in interest rates, as well as the expectation that indices like the S&P 500 will surge higher, has some important considerations for penny stocks. Penny stocks tend to do better when the downward pressures on their valuations subside.